Sign in
4

Changes in Ownership

Vistagen Therapeutics, Inc. Filed Acc 0001415889-21-003391

VP, CFO AND SECRETARY acquired 89,742 shares (option exercise)

  • VP, CFO AND SECRETARY acquired 3,044 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Grant or award +3,044 $1.95 $5,925 13,044 D
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Option exercise +1,000 $1.50 $1,500 14,044 D
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Option exercise +78,918 $1.00 $78,918 92,962 D
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Option exercise +9,824 $0.40 $3,910 102,786 D
Derivatives
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Option exercise · Stock Option (Right to Buy) −1,000 0 D
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Returned to the company · Stock Option (Right to Buy) −36,707 113,293 D
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Option exercise · Stock Option (Right to Buy) −78,918 34,375 D
DOTSON JERROLD DUANE VP, CFO AND SECRETARY 2021-06-30 Option exercise · Stock Option (Right to Buy) −9,824 140,176 D
Loading xslF345X03/form4-07022021_040729.xml…